Markus Hohenfellner
Heidelberg University, University Hospital Heidelberg, Gerresheimer (Germany)
Papers
15
Total Citations
418
H-Index
12
About
Markus Hohenfellner is a prominent urological surgeon and researcher whose work has significantly advanced the field of minimally invasive prostate cancer surgery, with a particular focus on radical prostatectomy techniques and patient outcomes. Based at a leading European urology center, Hohenfellner has made landmark contributions through his leadership of the LAP-01 trial — the first multicenter, randomized, patient-blinded controlled trial comparing robotic-assisted and laparoscopic radical prostatectomy — which has accumulated over 175 citations across its primary and follow-up publications and established a new benchmark for evidence-based surgical comparison. His research spans continence recovery prediction, the innovative Retzius-sparing robotic approach for aggressive prostate cancer, and the role of multiparametric MRI in surgical planning and risk stratification. Hohenfellner has also investigated surgical applicability in complex patient populations, including renal transplant recipients, and pioneered the evolution of salvage radical prostatectomy from open to robotic techniques. His body of work consistently bridges technical innovation with patient-centered outcomes — including quality of life and functional recovery — making him an influential voice in contemporary urologic oncology and a key reference for surgeons and researchers navigating the rapidly evolving landscape of prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Predictive factors for immediate continence after radical prostatectomy44 citations · 2015
- 4
- 5
- 6
- 7
- 8
- 9
- 10